Immunotherapy agents for treatment of IgE mediated allergies

Details Immunotherapy agents for treatment of IgE mediated allergies Immunotherapy agents for treatment of IgE mediated allergies

1990-06-07

1992-05-26

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Lymphokine

Interleukin

424 851, 424 854, 424 88, 424 89, 424 91, 424 92, 530403, 530404, 530405, 530406, 530351, 530409, 530410, A61K 3766, A61K 39385, C07K 1526, C07K 1702

Patent

active

051166127

ABSTRACT:
A protein conjugate or mixture useful in immunotherapy composed of a biological response modifier (BRM) and an allergen is disclosed. In use the protein conjugate or mixture is combined with a pharmaceutically acceptable carrier. Cytokines, bacterial, fungal and viral immunopotentiators and thymus hormones are disclosed as suitable BRM's for use in the invention.

REFERENCES:
patent: 4801578 (1989-01-01), Monsigny et al.
patent: 4830852 (1989-05-01), Marburg et al.
patent: 4946945 (1990-08-01), Wojdani
Van Brunt, J. Biotechnology vol. 7 Jul. issue 1989, p. 663.

Affiliated with

Also associated with

Rating

Immunotherapy agents for treatment of IgE mediated allergies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapy agents for treatment of IgE mediated allergies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapy agents for treatment of IgE mediated allergies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-418180